USPTO serial 97775510
XENIUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 22, 2024
- Examiner
- LINDEMYER, ANKHI MUKHERJEA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XENIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pleasanton, CA, US
Pleasanton, CA, US
Pleasanton, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carla B. Oakley
Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP600 Montgomery Street, Suite 2300SAN FRANCISCO, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | reagents, assays, enzymes, labeled and unlabeled nucleic acids; monoclonal antibodies for in vitro screening and labeling of nucleic acids and proteins within tissue samples; buffer solutions for scientific and medical research purposes; kits comprised of reagents and reagent-treated glass slides for biological analysis for medical research and scientific research purposes; kits comprised of reagents and single-use laboratory bottles and laboratory pipette tips for scientific and medical research purposes; chemical, biochemical and biological preparations for scientific and medical research purposes; combinations of multiple biochemical reagents commonly known as probes, each targeted to one or more biological analytes for detection of those biological analytes for scientific and medical research purposes | ACTIVE | Dec 8, 2022 |
| 009 | Laboratory equipment, namely, instruments for detection of biological molecules in tissue samples, visualization of cells, and data analysis for scientific and medical research purposes, namely, in situ analyzers; recorded and downloadable computer software for the operation and control of scientific and medical research instruments; recorded and downloadable computer software for processing, qualifying, quantifying, imaging, analysis or storage of medical and scientific research data and results regarding the spatial location or quantities of biological molecules in tissue samples; kits comprised of glass slides and reagents for scientific and medical research purposes | ACTIVE | Dec 8, 2022 |
| 042 | scientific research and development; scientific and technological research and development in the fields of spatial analysis, in-situ detection, genomics, proteomics, transcriptomics, cell differentiation, cell segmentation, and gene expression; providing scientific information in the fields of spatial analysis, in-situ detection, genomics, proteomics, transcriptomics, cell differentiation, cell segmentation, and gene expression; preparation of biological samples and assays for scientific and medical research; biological analysis of biological samples and assays for scientific and medical research; design and development of instruments for scientific analysis, namely, in situ analyzers; technical support services for computer software installation, maintenance and troubleshooting; providing scientific advice and consultancy in the fields of spatial analysis, in-situ detection, genomics, proteomics, transcriptomics, cell differentiation, cell segmentation, and gene expression | ACTIVE | Apr 25, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 10X Genomics, Inc.
- Other trademarks owned by 10X Genomics, Inc.
- Other trademarks owned by 10X Genomics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named XENIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 7, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 7, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 22, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 22, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 19, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 23, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 22, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 26, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jun 26, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 26, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 1, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 1, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 1, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2023 | NWAP | NEW APPLICATION ENTERED | — |